Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Piccoli

Showing results (191-200 of 301) with videos related to

Pageof 31
Sort By:
Clinical Biochemistry|October 1, 1983
Actual role of pepsinogen group I in the study of upper gastrointestinal diseasesM Plebani, F Di Mario, F Vianello, et al.
Journal of Clinical Chemistry and Clinical Biochemistry. Zeitschrift Fur Klinische Chemie Und Klinische Biochemie|September 1, 1983
Urinary ribonuclease excretion in pancreatic diseaseC Fabris, A Meani, R Farini, et al.
Journal of Autoimmunity|March 26, 2004
Antinucleosome antibodies in SLE: a two-year follow-up study of 101 patientsA Ghirardello, A Doria, S Zampieri, et al.
Enzyme|January 1, 1986
Serum elastase 1 and immunoreactive trypsin in chronic pancreatic disease: is there any relationship with trypsin inhibitors?C Fabris, G Del Favero, A Panucci, et al.
American Journal of Human Genetics|June 15, 2006
NOTCH2 mutations cause Alagille syndrome, a heterogeneous disorder of the notch signaling pathwayRyan McDaniell, Daniel M Warthen, Pedro A Sanchez-Lara, et al.
Journal of Clinical Gastroenterology|April 25, 2000
Azathioprine and 6-mercaptopurine for the treatment of perianal Crohn's disease in childrenW C Jeshion, K L Larsen, A F Jawad, et al.
International Journal of Pancreatology : Official Journal of the International Association of Pancreatology|January 1, 1990
Different role of liver dysfunction and damage in increasing serum CA 19-9, TPA, and CEA in patients with pancreatic cancerC Fabris, D Basso, T Meggiato, et al.
International Journal of Clinical Pharmacology and Therapeutics|June 5, 2003
Effect of epoetin on HO-1 mRNA level and plasma antioxidants in hemodialysis patientsL A Calò, L Stanic, P A Davis, et al.
Pancreas|January 1, 1988
Renal factors in serum trypsinogen 1 metabolism and excretion in chronic pancreatic diseaseC Fabris, L Benini, D Basso, et al.
La Ricerca in Clinica E in Laboratorio|July 1, 1984
Serum tissue polypeptide antigen in chronic pancreatic disease. Does hepatic damage have any influence?A Panucci, G De Silvestro, C Fabris, et al.
Pageof 31

Showing results (191-200 of 301) with videos related to

Sort By:
Pageof 31
Clinical Biochemistry|October 1, 1983
Actual role of pepsinogen group I in the study of upper gastrointestinal diseasesM Plebani, F Di Mario, F Vianello, et al.
Journal of Clinical Chemistry and Clinical Biochemistry. Zeitschrift Fur Klinische Chemie Und Klinische Biochemie|September 1, 1983
Urinary ribonuclease excretion in pancreatic diseaseC Fabris, A Meani, R Farini, et al.
Journal of Autoimmunity|March 26, 2004
Antinucleosome antibodies in SLE: a two-year follow-up study of 101 patientsA Ghirardello, A Doria, S Zampieri, et al.
Enzyme|January 1, 1986
Serum elastase 1 and immunoreactive trypsin in chronic pancreatic disease: is there any relationship with trypsin inhibitors?C Fabris, G Del Favero, A Panucci, et al.
American Journal of Human Genetics|June 15, 2006
NOTCH2 mutations cause Alagille syndrome, a heterogeneous disorder of the notch signaling pathwayRyan McDaniell, Daniel M Warthen, Pedro A Sanchez-Lara, et al.
Journal of Clinical Gastroenterology|April 25, 2000
Azathioprine and 6-mercaptopurine for the treatment of perianal Crohn's disease in childrenW C Jeshion, K L Larsen, A F Jawad, et al.
International Journal of Pancreatology : Official Journal of the International Association of Pancreatology|January 1, 1990
Different role of liver dysfunction and damage in increasing serum CA 19-9, TPA, and CEA in patients with pancreatic cancerC Fabris, D Basso, T Meggiato, et al.
International Journal of Clinical Pharmacology and Therapeutics|June 5, 2003
Effect of epoetin on HO-1 mRNA level and plasma antioxidants in hemodialysis patientsL A Calò, L Stanic, P A Davis, et al.
Pancreas|January 1, 1988
Renal factors in serum trypsinogen 1 metabolism and excretion in chronic pancreatic diseaseC Fabris, L Benini, D Basso, et al.
La Ricerca in Clinica E in Laboratorio|July 1, 1984
Serum tissue polypeptide antigen in chronic pancreatic disease. Does hepatic damage have any influence?A Panucci, G De Silvestro, C Fabris, et al.
Pageof 31